CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Alendronate sodium / cholecalciferol

Last Updated: December 18, 2008
Result type: Reports
Project Number: SR0153-000
Product Line: Reimbursement Review

Generic Name: Alendronate sodium / cholecalciferol

Brand Name: Fosavance 70/5600

Manufacturer: Merck Frosst Canda Ltd.

Therapeutic Area: Osteoporosis

Indications: Osteoporosis

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: June 17, 2009

Recommendation Type: List in a similar manner to other drugs in class